These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8683904)

  • 1. Beyond oxidized LDL: the initiation and progression of atherosclerosis.
    Hirose N; Arai Y; Kawamura M; Shigematu H
    Keio J Med; 1996 Jun; 45(2):90-4. PubMed ID: 8683904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase.
    Kaplan M; Aviram M
    Clin Chem Lab Med; 1999 Aug; 37(8):777-87. PubMed ID: 10536926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of oxidized low density lipoprotein in atherogenesis.
    Jialal I; Devaraj S
    J Nutr; 1996 Apr; 126(4 Suppl):1053S-7S. PubMed ID: 8642431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis.
    Parthasarathy S; Steinberg D; Witztum JL
    Annu Rev Med; 1992; 43():219-25. PubMed ID: 1580586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
    Aviram M
    Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation of lipoproteins and atherosclerosis.
    Luc G; Fruchart JC
    Am J Clin Nutr; 1991 Jan; 53(1 Suppl):206S-209S. PubMed ID: 1985389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized LDL and atherogenesis.
    Ylä-Herttuala S
    Ann N Y Acad Sci; 1999 Jun; 874():134-7. PubMed ID: 10415527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized lipoproteins, altered cell function and atherosclerosis.
    Penn MS; Chisolm GM
    Atherosclerosis; 1994 Aug; 108 Suppl():S21-9. PubMed ID: 7802725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants.
    Aviram M
    Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):599-608. PubMed ID: 8877334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of atherosclerosis: an overview.
    Schwartz CJ; Valente AJ; Sprague EA; Kelley JL; Nerem RM
    Clin Cardiol; 1991 Feb; 14(2 Suppl 1):I1-16. PubMed ID: 2044253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis.
    Heinecke JW
    Atherosclerosis; 1998 Nov; 141(1):1-15. PubMed ID: 9863534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retention of oxidized LDL by extracellular matrix proteoglycans leads to its uptake by macrophages: an alternative approach to study lipoproteins cellular uptake.
    Kaplan M; Aviram M
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):386-93. PubMed ID: 11231918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of ixidized low density lipoprotein in atherosclerosis].
    Hansen PR
    Ugeskr Laeger; 1996 May; 158(19):2706-10. PubMed ID: 8744072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized lipoproteins in atherosclerosis and thrombosis.
    Holvoet P; Collen D
    FASEB J; 1994 Dec; 8(15):1279-84. PubMed ID: 8001740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.
    Napoli C
    G Ital Cardiol; 1997 Dec; 27(12):1302-14. PubMed ID: 9470066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis.
    Rosenfeld ME; Palinski W; Ylä-Herttuala S; Carew TE
    Toxicol Pathol; 1990; 18(4 Pt 1):560-71. PubMed ID: 2091235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis.
    Ylä-Herttuala S
    Ann Med; 1991; 23(5):561-7. PubMed ID: 1721825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation.
    Naderi GA; Asgary S; Sarraf-Zadegan N; Shirvany H
    Mol Cell Biochem; 2003 Apr; 246(1-2):193-6. PubMed ID: 12841362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein and oxidised low-density lipoprotein: their role in the development of atherosclerosis.
    Hamilton CA
    Pharmacol Ther; 1997; 74(1):55-72. PubMed ID: 9336016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red wine administration to apolipoprotein E-deficient mice reduces their macrophage-derived extracellular matrix atherogenic properties.
    Kaplan M; Aviram M
    Biol Res; 2004; 37(2):239-45. PubMed ID: 15455653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.